DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 141 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,000 | -20.0% | 494 | 0.0% | 0.00% | -25.0% |
Q4 2018 | $5,000 | -16.7% | 494 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $6,000 | -25.0% | 494 | 0.0% | 0.01% | -28.6% |
Q2 2018 | $8,000 | -20.0% | 494 | 0.0% | 0.01% | -22.2% |
Q1 2018 | $10,000 | +11.1% | 494 | 0.0% | 0.01% | +12.5% |
Q4 2017 | $9,000 | – | 494 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |